Cargando…

Comparison of Models for Tumor Recurrence after Liver Transplantation for the Patients with Hepatocellular Carcinoma: A Multicenter Long-Term Follow-Up Study

Background and Aims: Several models have been developed to predict tumor the recurrence of hepatocellular carcinoma (HCC) after liver transplantation besides the conventional Milan criteria (MC), including the MoRAL score. This study aimed to compare the prognostication power of the MoRAL score to m...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chang, Young, Cho, Yuri, Lee, Jeong-Hoon, Lee, Yun Bin, Cho, Eun Ju, Yu, Su Jong, Sinn, Dong Hyun, Kim, Bo Hyun, Kim, Seoung Hoon, Yi, Nam-Joon, Lee, Kwang-Woong, Kim, Jong Man, Park, Joong-Won, Kim, Yoon Jun, Yoon, Jung-Hwan, Joh, Jae-Won, Suh, Kyung-Suk
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2019
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6769632/ https://www.ncbi.nlm.nih.gov/pubmed/31484287 http://dx.doi.org/10.3390/cancers11091295

Ejemplares similares

Novel Model to Predict HCC Recurrence after Liver Transplantation Obtained Using Deep Learning: A Multicenter Study
por: Nam, Joon Yeul, et al.
Publicado: (2020)

Clinical impact of the treatment modality on small, solitary, recurrent intrahepatic hepatocellular carcinomas after primary liver resection
por: Kim, Hyo-Sin, et al.
Publicado: (2021)

Comparison of treatment outcome between living donor liver transplantation and sorafenib for patients with hepatocellular carcinoma beyond the Milan criteria
por: Cho, Yuri, et al.
Publicado: (2017)

Early disseminated recurrence after liver resection in solitary hepatocellular carcinoma
por: Kim, Jong Man, et al.
Publicado: (2018)

Efficacy of Sorafenib for the Treatment of Post-Transplant Hepatocellular Carcinoma Recurrence
por: Kang, Seong Hee, et al.
Publicado: (2018)

Use of direct antiviral agents in liver transplant recipients with hepatitis C virus in Korea: 2-center experience
por: Kim, Jong Man, et al.
Publicado: (2018)

A novel prognostic factor for hepatocellular carcinoma: protein disulfide isomerase
por: Yu, Su Jong, et al.
Publicado: (2014)

Outcomes for patients with HCV after liver transplantation in Korea: a multicenter study
por: Kim, Jong Man, et al.
Publicado: (2016)

Ruptured Massive Hepatocellular Carcinoma Cured by Transarterial Chemoembolization
por: Lee, Ji Eun, et al.
Publicado: (2020)

A multicenter experience with generic mycophenolate mofetil conversion in stable liver transplant recipients
por: Kim, Jong Man, et al.
Publicado: (2014)

Survival Analysis of Single Large (>5 cm) Hepatocellular Carcinoma Patients: BCLC A versus B
por: Cho, Yuri, et al.
Publicado: (2016)

A prospective randomized study comparing radiofrequency ablation and hepatic resection for hepatocellular carcinoma
por: Lee, Hae Won, et al.
Publicado: (2018)

Living donor liver transplantation should be cautiously considered as initial treatment in recurrent hepatocellular carcinoma within the Milan criteria after curative liver resection
por: Kim, Jong Man, et al.
Publicado: (2020)

Assessment of the Surveillance Interval at 1 Year after Curative Treatment in Hepatocellular Carcinoma: Risk Stratification
por: Lee, Minjong, et al.
Publicado: (2018)

A circulating cell-free DNA methylation signature for the detection of hepatocellular carcinoma
por: Kim, Si-Cho, et al.
Publicado: (2023)

Validation for models for tumor recurrence after liver transplantation in hepatectomy patients
por: Kim, Sung Joon, et al.
Publicado: (2022)

Adjuvant cytokine-induced killer cell immunotherapy for hepatocellular carcinoma: a propensity score-matched analysis of real-world data
por: Yoon, Jun Sik, et al.
Publicado: (2019)

Tumor Marker-Based Definition of the Transarterial Chemoembolization-Refractoriness in Intermediate-Stage Hepatocellular Carcinoma: A Multi-Cohort Study
por: Yoon, Jun Sik, et al.
Publicado: (2019)

Comparison of Overall Survival between Surgical Resection and Radiofrequency Ablation for Hepatitis B-Related Hepatocellular Carcinoma
por: Hur, Moon Haeng, et al.
Publicado: (2021)

Transarterial radioembolization versus tyrosine kinase inhibitor in hepatocellular carcinoma with portal vein thrombosis
por: Hur, Moon Haeng, et al.
Publicado: (2023)

Integrative analysis of genomic and epigenomic regulation of the transcriptome in liver cancer
por: Woo, Hyun Goo, et al.
Publicado: (2017)

Modified AS1411 Aptamer Suppresses Hepatocellular Carcinoma by Up-Regulating Galectin-14
por: Cho, Yuri, et al.
Publicado: (2016)

A phase I/IIa study of adjuvant immunotherapy with tumour antigen-pulsed dendritic cells in patients with hepatocellular carcinoma
por: Lee, Jeong-Hoon, et al.
Publicado: (2015)

3-bromopyruvate and buthionine sulfoximine effectively kill anoikis-resistant hepatocellular carcinoma cells
por: Lee, Minjong, et al.
Publicado: (2017)

Immunosuppression status of liver transplant recipients with hepatitis C affects biopsy-proven acute rejection
por: Kim, Jong Man, et al.
Publicado: (2016)

Increased survival in hepatitis c patients who underwent living donor liver transplant: a case-control study with propensity score matching
por: Kim, Jong Man, et al.
Publicado: (2017)

Oral Medications Enhance Adherence to Surveillance for Hepatocellular Carcinoma and Survival in Chronic Hepatitis B Patients
por: Nam, Joon Yeul, et al.
Publicado: (2017)

Association of Polymorphism in Pri-microRNAs-371-372-373 with the Occurrence of Hepatocellular Carcinoma in Hepatitis B Virus Infected Patients
por: Kwak, Min-Sun, et al.
Publicado: (2012)

Serum Insulin-Like Growth Factor-1 Predicts Disease Progression and Survival in Patients with Hepatocellular Carcinoma Who Undergo Transarterial Chemoembolization
por: Cho, EunJu, et al.
Publicado: (2014)

Proposal of a New Risk Score for Patients Treated with Transarterial Chemoembolization due to Recurrent Hepatocellular Carcinoma after Curative Resection: A Multicenter Study
por: Jeon, Mi Young, et al.
Publicado: (2020)

Better survival of patients with hepatitis B virus-related hepatocellular carcinoma in South Korea: Changes in 16-years cohorts
por: Choi, Sang Il, et al.
Publicado: (2022)

Hepatocellular Carcinoma in Korea: an Analysis of the 2015 Korean Nationwide Cancer Registry
por: Yoon, Jun Sik, et al.
Publicado: (2021)

Comparative Analysis of Atezolizumab Plus Bevacizumab and Hepatic Artery Infusion Chemotherapy in Unresectable Hepatocellular Carcinoma: A Multicenter, Propensity Score Study
por: Kim, Ji Hoon, et al.
Publicado: (2023)

Early Enteral Feeding After Living Donor Liver Transplantation Prevents Infectious Complications: A Prospective Pilot Study
por: Kim, Jong Man, et al.
Publicado: (2015)

Tailored Prediction Model of Survival after Liver Transplantation for Hepatocellular Carcinoma
por: Jamtani, Indah, et al.
Publicado: (2021)

Metabolism-Associated Gene Signatures for FDG Avidity on PET/CT and Prognostic Validation in Hepatocellular Carcinoma
por: Lee, Hyunjong, et al.
Publicado: (2022)

Surveillance for hepatocellular carcinoma: It is time to move forward
por: Kim, Bo Hyun, et al.
Publicado: (2022)

Sirolimus Prolongs Survival after Living Donor Liver Transplantation for Hepatocellular Carcinoma Beyond Milan Criteria: A Prospective, Randomised, Open-Label, Multicentre Phase 2 Trial
por: Lee, Kwang-Woong, et al.
Publicado: (2020)

All-treatment array of hepatocellular carcinoma from initial diagnosis to death: observation of cumulative treatments
por: Moon, Hae, et al.
Publicado: (2017)

Current status and strategies for the control of viral hepatitis A in Korea
por: Yoon, Eileen L., et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_9b5ca6j6p0l6oo8amgupc4dnqv